Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Voyager Therapeutics (VYGR) Total Non-Current Liabilities (2016 - 2024)

Historic Total Non-Current Liabilities for Voyager Therapeutics (VYGR) over the last 10 years, with Q3 2024 value amounting to $56.4 million.

  • Voyager Therapeutics' Total Non-Current Liabilities fell 4336.17% to $56.4 million in Q3 2024 from the same period last year, while for Sep 2024 it was $56.4 million, marking a year-over-year decrease of 4336.17%. This contributed to the annual value of $96.9 million for FY2023, which is 2255.29% up from last year.
  • Voyager Therapeutics' Total Non-Current Liabilities amounted to $56.4 million in Q3 2024, which was down 4336.17% from $59.6 million recorded in Q2 2024.
  • Voyager Therapeutics' Total Non-Current Liabilities' 5-year high stood at $211.8 million during Q1 2020, with a 5-year trough of $56.3 million in Q3 2021.
  • Moreover, its 5-year median value for Total Non-Current Liabilities was $80.6 million (2022), whereas its average is $91.5 million.
  • In the last 5 years, Voyager Therapeutics' Total Non-Current Liabilities tumbled by 7243.87% in 2021 and then soared by 8868.5% in 2022.
  • Quarter analysis of 5 years shows Voyager Therapeutics' Total Non-Current Liabilities stood at $62.9 million in 2020, then decreased by 5.83% to $59.2 million in 2021, then soared by 33.54% to $79.0 million in 2022, then rose by 22.55% to $96.9 million in 2023, then plummeted by 41.81% to $56.4 million in 2024.
  • Its Total Non-Current Liabilities stands at $56.4 million for Q3 2024, versus $59.6 million for Q2 2024 and $85.7 million for Q1 2024.